convulsions
Our study suggests that the ability of Ang IV to inhibit pilocarpine-induced convulsions is dependent on somatostatin receptor-2 activation, and is possibly mediated via the inhibition of IRAP resulting in an elevated concentration of somatostatin-14 in the brain.
Our study suggests that the ability of Ang IV to inhibit pilocarpine-induced <span class="disease" id="16771832-5-77-88">convulsions</span> is dependent on <span class="gene" id="16771832-5-105-128">somatostatin receptor-2</span> activation, and is possibly mediated via the inhibition of IRAP resulting in an elevated concentration of somatostatin-14 in the brain.